# BridgeBio Pharma, Inc.: Form 4, filed Mar 7, 2025

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 4
- Filed: 2025-03-07
- Accepted by EDGAR: Mar 7, 2025, 18:09 ET
- Period: 2025-03-05
- Accession: 0001140361-25-007699
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036125007699/xslF345X05/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036125007699/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036125007699/xslF345X05/form4.xml

Filed Mar 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-007699. Last ingested by Listed: Nov 3, 2026, 19:31 ET. No prices; not investment advice.